Winfield Associates’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-77
Closed -$15K 605
2017
Q4
$15K Buy
77
+9
+13% +$1.72K 0.01% 366
2017
Q3
$13K Hold
68
0.01% 384
2017
Q2
$12K Buy
68
+21
+45% +$3.53K 0.01% 386
2017
Q1
$7K Buy
47
+3
+7% +$459 ﹤0.01% 435
2016
Q4
$6K Sell
44
-110
-71% -$16.2K ﹤0.01% 410
2016
Q3
$24K Hold
154
0.02% 235
2016
Q2
$23K Buy
154
+134
+670% +$19.8K 0.02% 241
2016
Q1
$3K Buy
+20
New +$2.68K ﹤0.01% 461

Other funds holding TMO

Winfield Associates's TMO Position: Q1 2018 in Review

Winfield Associates sold out of Thermo Fisher Scientific (TMO) in Q1 2018, closing a stake of 77 shares — an estimated $15K sold.

Winfield Associates first reported a position in TMO in Q1 2016 and held it in 8 quarters. The position peaked at $24K in Q3 2016. 1,305 funds tracked by Wall St. Rank hold TMO as of Q1 2018.

  • Winfield Associates reported no remaining Thermo Fisher Scientific position as of Q1 2018 after selling out during the quarter.
  • Winfield Associates sold 77 Thermo Fisher Scientific shares in Q1 2018, an estimated $15K.
  • Winfield Associates first reported a position in Thermo Fisher Scientific in Q1 2016 and held it in 8 quarters.
  • Winfield Associates's Thermo Fisher Scientific position peaked at $24K in Q3 2016.
  • 1,305 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2018.

Based on Winfield Associates's 13F filing for Q1 2018, filed 10 May 2018.